Clinical Trial Update: QL1706 in the Treatment of Advanced Bone and Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

An update on an ongoing Phase 2 trial evaluating QL1706 for advanced bone cancer and soft tissue sarcoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Soft Tissue Sarcoma

Drugs mentioned

• QL1706

Snippet

Sponsor: Sun Yat-sen University | Conditions: Bone and Soft Tissue Tumors | Phase 2 | Status: RECRUITING